0001562180-21-005317.txt : 20210813
0001562180-21-005317.hdr.sgml : 20210813
20210813200440
ACCESSION NUMBER: 0001562180-21-005317
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210813
DATE AS OF CHANGE: 20210813
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalb Michael Wayne
CENTRAL INDEX KEY: 0001678248
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 211174007
MAIL ADDRESS:
STREET 1: 24 LUCILLE LANE
CITY: DIX HILLS
STATE: NY
ZIP: 11746
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-08-12
false
0000897448
AMARIN CORP PLC\UK
AMRN
0001678248
Kalb Michael Wayne
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
false
true
false
false
SVP and CFO
Ordinary Shares
2021-08-12
4
M
false
95000.00
2.19
A
300010.00
D
Ordinary Shares
2021-08-12
4
M
false
25000.00
2.95
A
325010.00
D
Ordinary Shares
2021-08-12
4
S
false
120000.00
5.252
D
205010.00
D
Stock Option (Right to Buy)
2.19
2021-08-12
4
M
false
95000.00
0.00
D
2026-07-01
Ordinary Shares
95000.00
55000.00
D
Stock Option (Right to Buy)
2.95
2021-08-12
4
M
false
25000.00
0.00
D
2027-01-31
Ordinary Shares
25000.00
39000.00
D
The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On July 1, 2016, the Reporting Person was granted an option to purchase 625,000 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). The shares subject to this option vested and became exercisable as follows: 25% of the total number of underlying shares vested on July 1, 2017, and the remaining 75% of the underlying shares vested ratably over the subsequent 36 months. This option was fully vested as of the date hereof.
On February 1, 2017, the Reporting Person was granted an option to purchase 133,000 Ordinary Shares under the Plan. The shares subject to this option vested and became exercisable in 48 equal monthly installments on the last day of each month starting on February 28, 2017. This option was fully vested as of the date hereof.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.25 to $5.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Please see the section titled "Remarks" below for additional information.
As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 1,291,417 Ordinary Shares of the Issuer in the form of Ordinary Shares, stock options and RSUs outstanding under the Issuer's stock incentive plans, including but not limited to certain performance-based RSUs that are earned only if certain pre-defined operational milestones are achieved and, in certain cases, then vest only if the recipient remains with the company for an extended period of time.
/s/ Michael W. Kalb
2021-08-13